Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01368510 · ClinicalTrials.gov registry record · NA
Intensive Cognitive-Behavioral Therapy For Obsessive-Compulsive Disorder
A NA study of Obsessive Compulsive Disorder (OCD), sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 75
- Enrollment target
- 1
- Study location
NCT01368510: Completed NA study of Obsessive Compulsive Disorder (OCD), sponsored by University of California, Los Angeles.
NCT01368510 is a NA study of Obsessive Compulsive Disorder (OCD) that has completed, run by University of California, Los Angeles. The registered enrollment target is 75 participants, below the 237-participant average among 12 other Obsessive Compulsive Disorder (OCD) trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01368510, a NA study of Obsessive Compulsive Disorder (OCD), has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
Even with the best available treatments for obsessive-compulsive disorder (OCD), most patients only partially recover and many patients do not respond at all. Such incomplete and inadequate response contributes to greater public health costs in terms of morbidity and patient care expenses. This study aims for a better understanding of abnormal brain chemistry in OCD and how it is affected by cognitive-behavioral therapy (CBT) in order to develop novel therapies and improve the success of existing therapies. The main hypothesis is that CBT will change levels of the excitatory neurotransmitter glutamate in OCD patients in a region of the brain involved in OCD known as the cingulate cortex.
Primary Outcome
Regional concentration of glutamate in brain, as measured by magnetic resonance spectroscopic imaging (MRSI)
Conditions Studied
Interventions
- BEHAVIORAL Waitlist
- BEHAVIORAL Intensive Cognitive Behavioral Therapy (CBT)
Study Locations (1)
California
- UCLA Obsessive-Compulsive Disorder Intensive Treatment Program - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2011-07 |
| Est. Completion | 2015-06 |
| Phase | NA |
What the finished NCT01368510 record still lists
NCT01368510 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 237-participant average among 12 other Obsessive Compulsive Disorder (OCD) trials with a reported enrollment target (68% lower).
The record links to 1 condition, with Obsessive Compulsive Disorder (OCD) appearing as the primary indexed condition, and to 2 interventions - of which Waitlist is the first listed.
NCT01368510 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01368510 about?
NCT01368510 is a clinical study titled "Intensive Cognitive-Behavioral Therapy For Obsessive-Compulsive Disorder". Even with the best available treatments for obsessive-compulsive disorder (OCD), most patients only partially recover and many patients do not respond at all. Such incomplete and inadequate response contributes to greater public health costs in terms of morbidity and patient care expenses. This stud...
What is the current status of trial NCT01368510?
This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2011-07. Estimated completion is 2015-06.
What conditions does trial NCT01368510 study?
This clinical trial studies the following conditions: Obsessive Compulsive Disorder (OCD).
What interventions are being tested in trial NCT01368510?
The interventions under investigation include: Waitlist (BEHAVIORAL), Intensive Cognitive Behavioral Therapy (CBT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT01368510?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01368510 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obsessive Compulsive Disorder (OCD)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01368510's enrollment target sits among peer trials
75 8th of 12 higher than 5 of 12 other Obsessive Compulsive Disorder (OCD) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obsessive Compulsive Disorder (OCD) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Transcranial Direct Current Stimulation and Extinction in Obsessive Compulsive Disorder
RECRUITING · NA
-
ERP to Improve Functioning in Veterans With OCD
RECRUITING · NA
-
Connectomic Deep Brain Stimulation for Obsessive Compulsive Disorder
RECRUITING · NA
-
Stepped Care Treatment for Anxiety Resilience
RECRUITING · NA
-
Implementing Team-Based Treatment for Pediatric Anxiety in Community Mental Health Settings
RECRUITING · NA
-
Comparative Effectiveness of Internet-based Versus Parent-Coached Cognitive-Behavioral Therapy For Children and Adolescents With Anxiety and OCD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia